Zobrazeno 1 - 10
of 54
pro vyhledávání: '"B. Tolu"'
PO-1401 MR-guided adaptive versus CT-guided SBRT for prostate cancer: where is cost-benefit balance?
Autor:
A. Castelluccia, D. Marchesano, G. Grimaldi, I. Annessi, F. Bianciardi, A. Di Palma, V. Confaloni, F. Rea, B. Tolu, M. Valentino, L. Verna, M. Rago, C. Borrazzo, L. Capone, M. Masi, R. El Gawhary, P. Gentile
Publikováno v:
Radiotherapy and Oncology. 170:S1188-S1189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8ab2643b38e5564b724ada5b0727679
https://doi.org/10.1016/s0167-8140(22)03365-5
https://doi.org/10.1016/s0167-8140(22)03365-5
Autor:
A. Castelluccia, D. Marchesano, G. Grimaldi, I. Annessi, F. Bianciardi, A. Di Palma, M. Valentino, L. Verna, V. Confaloni, F. Rea, B. Tolu, C. Borrazzo, M. Rago, M. Masi, R. El Gawhary, P.C. Gentile
Publikováno v:
European Urology. 81:S1412
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1aea19530790e5ca792a84f5d59033c
https://doi.org/10.1016/s0302-2838(22)01037-5
https://doi.org/10.1016/s0302-2838(22)01037-5
Autor:
M. Bevilacqua, Pasquale Niscola, P. de Fabrititis, Roberto Palumbo, B. Tolu, Francesco Bondanini, S. Fierimonte, Laura Scaramucci, S. Calabria
Publikováno v:
Gefässchirurgie. 15:108-112
Hintergrund Bei fehlenden oberflachlichen Venen stellen kunstliche Prothesen eine Moglichkeit fur den arteriovenosen (AV)-Zugang bei chronischer Niereninsuffizienz dar. Diese Prothesen (AV-Grafts, AVG) sind jedoch durch eine hohe Versagerquote gekenn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6270d665a804c6acfe8762f633260df
https://doi.org/10.1007/s00772-010-0791-0
https://doi.org/10.1007/s00772-010-0791-0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P, Niscola, L, Scaramucci, C, Romani, L, Cupelli, A, Tendas, T, Dentamaro, M, Ales, M, Giovannini, D, Piccioni, A, Siniscalchi, B, Tolu, A, Perrotti, D, Keefe, P, de Fabritiis
Publikováno v:
Annals of Oncology. 19:vii141-vii145
P. Niscola, L. Scaramucci, C. Romani, L. Cupelli, A. Tendas, T. Dentamaro, M. Ales, M. Giovannini, D. Piccioni, B. Tolu, M. Giovannini, A. Perrotti, D. Keefe and P. de Fabritiis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f63c1b8cf96cd56e28c6038d700f0c
https://doi.org/10.1093/annonc/mdn462
https://doi.org/10.1093/annonc/mdn462
Autor:
Pasquale Niscola, B Tolu, Daniela Piccioni, Roberto Palumbo, Claudio Romani, Andrea Tendas, Claudio Cartoni, Laura Scaramucci, Marco Giovannini, Edoardo Arcuri, Alessio Perrotti, Teresa Dentamaro, Luca Cupelli, P. De Fabritiis
Publikováno v:
Bone Marrow Transplantation. 41:757-764
Severe pain syndromes may be recorded during all phases of haematopoietic stem cell transplantation (HSCT) for haematological malignancies: from stem cell mobilization to the long-term post transplant period. Although the major cause of pain in the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da52bdc1b5e0fa2453701928c3ae14e
https://doi.org/10.1038/bmt.2008.3
https://doi.org/10.1038/bmt.2008.3
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
Autor:
C. Caruso, L. Laterza, C. R. Settanni, S. Colantuono, C. Di Mario, B. Tolusso, F. Castrì, E. Gremese, F. Scaldaferri, A. Armuzzi, C. De Simone, K. Peris, A. Chiricozzi, A. Gasbarrini
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
We described a case of IPEX syndrome successfully controlled with dupilumab, an anti-IL4 receptor alpha subunit inhibitor. IPEX syndrome is a rare and generally fatal genetic disorder characterized by immune dysregulation, polyendocrinopathy and ente
Externí odkaz:
https://doaj.org/article/96e741e104df4a0583ef8abba24751dc
Autor:
R, Barbarino, D, Janniello, P, Morelli, M D, Falco, S, Cicchetti, L, Di Murro, G, Tortorelli, P, Bagalà, D, Di Cristino, A, Murgia, S, Terenzi, E, Ponti, B, Tolu, R, Santoni
Fatigue can be defined as an unpleasant feeling of tiredness, weakness and lack of energy. It is found in about 80% of the patients receiving radiation therapy and has a significant impact on quality of life. The aim of this paper was to assess the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a7a34175efdfee545a7ab2cff5cf809c
http://hdl.handle.net/2108/79912
http://hdl.handle.net/2108/79912
Autor:
C. Caruso, S. Colantuono, D. Pugliese, C. Di Mario, B. Tolusso, E. Gremese, G. Papparella, F. Castrì, A. Gasbarrini, A. Romano, A. Armuzzi
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-5 (2020)
Abstract Background Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the treatment of severe refractory eosinophilic asthma. Case presentation We describe here the case of a 49 years-old woman with Aspirin-exacerbate
Externí odkaz:
https://doaj.org/article/61a57094ea0d4007b5d8a9285db72428
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.